SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-043372
Filing Date
2019-11-14
Accepted
2019-11-14 08:16:50
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q phas-10q_20190930.htm 10-Q 2380841
2 EX-31.1 phas-ex311_11.htm EX-31.1 16769
3 EX-31.2 phas-ex312_6.htm EX-31.2 16752
4 EX-32.1 phas-ex321_8.htm EX-32.1 7588
5 EX-32.2 phas-ex322_9.htm EX-32.2 7588
6 EX-4.8 phas-ex48_36.htm EX-4.8 144781
7 EX-4.9 phas-ex49_35.htm EX-4.9 147345
8 GRAPHIC g1o5feanw2ow000001.jpg GRAPHIC 837
  Complete submission text file 0001564590-19-043372.txt   6260550

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT phas-20190930.xml EX-101.INS 843322
10 XBRL TAXONOMY EXTENSION SCHEMA phas-20190930.xsd EX-101.SCH 45454
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phas-20190930_cal.xml EX-101.CAL 44056
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phas-20190930_def.xml EX-101.DEF 156188
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE phas-20190930_lab.xml EX-101.LAB 374502
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phas-20190930_pre.xml EX-101.PRE 276159
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 191216441
SIC: 2834 Pharmaceutical Preparations